MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor. MindChild expects feedback from the FDA during the next quarter and anticipates entering the US market with MERIDIAN following FDA pre-market clearance. Additional pre-market regulatory filings are anticipated during 2012.